Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapy

AF Gazdar - Cancer and Metastasis Reviews, 2010 - Springer
Non-small cell lung cancer (NSCLC) is the major cause of cancer-related deaths in the USA
and worldwide. Most patients present with advanced disease, and treatment options for …
被引用次数：129 相关文章

Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapy.

AF Gazdar - Cancer Metastasis Reviews, 2010 - europepmc.org
Non-small cell lung cancer (NSCLC) is the major cause of cancer-related deaths in the USA
and worldwide. Most patients present with advanced disease, and treatment options for …

Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapy

AF Gazdar - Cancer metastasis reviews, 2010 - pubmed.ncbi.nlm.nih.gov
Non-small cell lung cancer (NSCLC) is the major cause of cancer-related deaths in the USA
and worldwide. Most patients present with advanced disease, and treatment options for …
[PDF] researchgate.net

[PDF][PDF] Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapy

AF Gazdar - Cancer Metastasis Rev, 2010 - researchgate.net
Non-small cell lung cancer (NSCLC) is the major cause of cancer-related deaths in the USA
and worldwide. Most patients present with advanced disease, and treatment options for …

Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapy

AF Gazdar - Cancer and Metastasis Reviews, 2010 - search.proquest.com
Non-small cell lung cancer (NSCLC) is the major cause of cancer-related deaths in the USA
and worldwide. Most patients present with advanced disease, and treatment options for …

[引用][C] Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapy: Lung cancer

AF GAZDAR - Cancer metastasis reviews, 2010 - pascal-francis.inist.fr
Epidermal growth factor receptor inhibition in lung cancer: the evolving role of
individualized therapy : Lung cancer CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapy

AF Gazdar - Cancer and Metastasis Reviews, 2010 - infona.pl
Non-small cell lung cancer (NSCLC) is the major cause of cancer-related deaths in the USA
and worldwide. Most patients present with advanced disease, and treatment options for …

[引用][C] Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapy

AF Gazdar - Cancer and Metastasis Reviews, 2010 - cir.nii.ac.jp
Epidermal growth factor receptor inhibition in lung cancer: the evolving role of
individualized therapy | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
[HTML] nih.gov

[HTML][HTML] Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapy

AF Gazdar - Cancer Metastasis Reviews, 2010 - ncbi.nlm.nih.gov
Non-small cell lung cancer (NSCLC) is the major cause of cancer-related deaths in the USA
and worldwide. Most patients present with advanced disease, and treatment options for …

Epidermal growth factor receptor inhibition in lung cancer: The evolving role of individualized therapy

AF Gazdar - Cancer and Metastasis Reviews, 2010 - utsouthwestern.elsevierpure.com
Non-small cell lung cancer (NSCLC) is the major cause of cancer-related deaths in the USA
and worldwide. Most patients present with advanced disease, and treatment options for …